Marshall Wace
NARI

Marshall Wace’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Marshall Wace’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-44,809
Closed -$2.29M – 3195
2024
Q4 		$2.29M Buy
44,809
+3,450
+8% +$170K ﹤0.01% 1381
2024
Q3 		$1.71M Sell
41,359
-243,250
-85% -$11.7M ﹤0.01% 1431
2024
Q2 		$13.7M Sell
284,609
-434,290
-60% -$19.2M 0.02% 611
2024
Q1 		$34.5M Buy
718,899
+368,171
+105% +$19.7M 0.05% 341
2023
Q4 		$22.8M Sell
350,728
-113,179
-24% -$6.81M 0.04% 440
2023
Q3 		$30.3M Buy
463,907
+200,331
+76% +$12.6M 0.06% 317
2023
Q2 		$15.3M Sell
263,576
-131,857
-33% -$8.32M 0.03% 580
2023
Q1 		$24.4M Buy
+395,433
New +$23.7M 0.05% 398
2021
Q1 		– Sell
-19,150
Closed -$1.67M – 2939
2020
Q4 		$1.67M Buy
+19,150
New +$1.35M 0.01% 1022

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Marshall Wace's NARI Position: Q1 2025 in Review

Marshall Wace sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 44,809 shares — an estimated $2.29M sold.

Marshall Wace first reported a position in NARI in Q4 2020 and held it in 9 quarters. The position peaked at $34.5M in Q1 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Marshall Wace reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Marshall Wace sold 44,809 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $2.29M.
  • Marshall Wace first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • Marshall Wace's Inari Medical, Inc. Common Stock position peaked at $34.5M in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Marshall Wace's 13F filing for Q1 2025, filed 15 May 2025.